The Lovesac Company (NASDAQ:LOVE) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable

Simply Wall StMay 3 08:05 ET

Cannara Biotech Swings to Q2 Profit

MT NewswiresApr 28 09:11 ET

Craig-Hallum Maintains The Lovesac(LOVE.US) With Buy Rating, Announces Target Price $35

Moomoo NewsApr 12 03:31 ET · Ratings

D.A. Davidson Maintains The Lovesac(LOVE.US) With Buy Rating, Maintains Target Price $24

Moomoo NewsApr 12 03:31 ET · Ratings

Roth MKM Maintains The Lovesac(LOVE.US) With Buy Rating, Cuts Target Price to $28

Moomoo NewsApr 12 03:31 ET · Ratings

Lovesac Is Maintained at Buy by Canaccord Genuity

Dow JonesApr 11 10:12 ET · Ratings